Conformal proton therapy for early-stage prostate cancer.
暂无分享,去创建一个
J M Slater | Daniel W. Miller | L T Yonemoto | J D Slater | J. Slater | L. Yonemoto | S. Teichman | C. Rossi | D W Miller | D A Bush | C J Rossi | N J Reyes-Molyneux | J E Antoine | S L Teichman | J. Slater | D. Bush | N. Reyes-Molyneux | J. Antoine | D. Miller
[1] P. Schellhammer,et al. Results of radical prostatectomy in men with clinically localized prostate cancer. , 1996, JAMA.
[2] G E Hanks,et al. The effect of dose on local control of prostate cancer. , 1988, International journal of radiation oncology, biology, physics.
[3] A. V. von Eschenbach,et al. Prognostic factors for clinically localized prostate carcinoma , 1997, Cancer.
[4] H. Sandler,et al. Potential improvement in the results of irradiation for prostate carcinoma using improved dose distribution. , 1992, International journal of radiation oncology, biology, physics.
[5] M. Hunt,et al. Localized prostate cancer treated by external-beam radiotherapy alone: serum prostate-specific antigen--driven outcome analysis. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] A. Zietman,et al. Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome. , 1994, The Journal of urology.
[7] J. Oesterling,et al. Radical prostatectomy for clinically localized prostate cancer: long-term results of 1,143 patients from a single institution. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] R. Bociek,et al. Radiotherapy for localized prostate carcinoma , 1997, Cancer.
[9] P. Rubin,et al. Correlation of radiotherapeutic parameters and treatment related morbidity--analysis of RTOG Study 77-06. , 1986, International journal of radiation oncology, biology, physics.
[10] M. Zelefsky,et al. Three-dimensional conformal radiation therapy in localized carcinoma of the prostate: interim report of a phase 1 dose-escalation study. , 1994, The Journal of urology.
[11] Daniel W. Miller,et al. Combined proton and photon conformal radiation therapy for locally advanced carcinoma of the prostate: preliminary results of a phase I/II study. , 1997, International journal of radiation oncology, biology, physics.
[12] M. Goitein,et al. Multi-dimensional treatment planning: II. Beam's eye-view, back projection, and projection through CT sections. , 1983, International journal of radiation oncology, biology, physics.
[13] A Pollack,et al. Prostate-specific antigen and radiation therapy for clinically localized prostate cancer. , 1995, International journal of radiation oncology, biology, physics.
[14] M Goitein,et al. Multi-dimensional treatment planning: I. Delineation of anatomy. , 1983, International journal of radiation oncology, biology, physics.
[15] J. Slater,et al. Particle beam radiation therapy in prostate cancer: is there an advantage? , 1998, Seminars in radiation oncology.
[16] A. Pollack,et al. Radiation therapy for T1 and T2 prostate cancer: prostate-specific antigen and disease outcome. , 1995, Urology.
[17] A. Hanlon,et al. Late GI and GU complications in the treatment of prostate cancer. , 1997, International journal of radiation oncology, biology, physics.
[18] H. Sandler,et al. Three dimensional conformal radiotherapy for the treatment of prostate cancer: low risk of chronic rectal morbidity observed in a large series of patients. , 1995, International journal of radiation oncology, biology, physics.
[19] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[20] J M Slater,et al. The proton treatment center at Loma Linda University Medical Center: rationale for and description of its development. , 1992, International journal of radiation oncology, biology, physics.
[21] P. Wingo,et al. Cancer statistics, 1997 , 1997, CA: a cancer journal for clinicians.
[22] R Mohan,et al. Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: preliminary results of a phase I dose-escalation study. , 1994, International journal of radiation oncology, biology, physics.
[23] A W Partin,et al. Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. , 1993, The Urologic clinics of North America.
[24] T. Schultheiss,et al. Clinical and biochemical evidence of control of prostate cancer at 5 years after external beam radiation. , 1995, The Journal of urology.
[25] M Goitein,et al. Proton radiation as boost therapy for localized prostatic carcinoma. , 1979, JAMA.
[26] P. Kantoff,et al. NCCN Prostate Cancer Practice Guidelines. The National Comprehensive Cancer Network. , 1996, Oncology.
[27] W. Shipley,et al. Early prostate cancer: the national results of radiation treatment from the Patterns of Care and Radiation Therapy Oncology Group studies with prospects for improvement with conformal radiation and adjuvant androgen deprivation. , 1994, The Journal of urology.
[28] A. Zietman,et al. The treatment of prostate cancer by conventional radiation therapy: an analysis of long-term outcome. , 1995, International journal of radiation oncology, biology, physics.
[29] L. Verhey,et al. Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. , 1995, International journal of radiation oncology, biology, physics.
[30] J. Moul,et al. Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: long-term results. , 1990, The Journal of urology.
[31] D. Kuban,et al. Prostate-specific antigen for pretreatment prediction and posttreatment evaluation of outcome after definitive irradiation for prostate cancer. , 1995, International journal of radiation oncology, biology, physics.
[32] A. Zietman,et al. Use of PSA nadir to predict subsequent biochemical outcome following external beam radiation therapy for T1-2 adenocarcinoma of the prostate. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[33] A. K. Levinson,et al. Prostate-specific antigen nadir: the optimum level after irradiation for prostate cancer. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] P. Rubin,et al. Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706. , 1991, International journal of radiation oncology, biology, physics.
[35] T E Schultheiss,et al. Optimization of conformal radiation treatment of prostate cancer: report of a dose escalation study. , 1997, International journal of radiation oncology, biology, physics.
[36] J A Smith,et al. Results of radical prostatectomy in men with clinically localized prostate cancer. , 1996, JAMA.
[37] G C Morton,et al. Early prostate cancer. , 2000, Current problems in cancer.
[38] L. Verhey,et al. Fractionated Proton Radiation Therapy of Cranial and Intracranial Tumors , 1990, American journal of clinical oncology.
[39] J. Archambeau,et al. Proton radiation therapy. , 1974, Radiology.
[40] T. Schultheiss,et al. Conformal treatment of prostate cancer with improved targeting: superior prostate-specific antigen response compared to standard treatment. , 1995, International journal of radiation oncology, biology, physics.
[41] David R. Cox,et al. Regression models and life tables (with discussion , 1972 .
[42] E. Crawford,et al. Advanced prostate cancer , 1999, Prostate Cancer and Prostatic Diseases.
[43] James D. Cox,et al. Consensus statement: Guidelines for PSA following radiation therapy , 1997 .